Pharma channel feed – Endpoints News

Pharma channel feed

FDA forces Concert Pharma to hit the brakes on a mid-stage study so it can review tox studies

8 years ago

FDA shoves Bayer’s lymphoma drug copanlisib into the spotlight with its promise of a speedy review

8 years ago

Overwrought marketing? Ads, not research, create some pharma best-sellers

8 years ago

X-Chem forges another discovery deal, this time with Vertex

8 years ago

FDA commissioner Scott Gottlieb sets some goals: Find ways to lower drug prices, use new tech to speed development

8 years ago

Akebia adds $50M deal with Vifor for exclusive US distribution deal for vadadustat

8 years ago

With major backing from New York and China, Athenex sets sights on a $100M cancer drug IPO

8 years ago

Can Dendreon’s new Provenge data help ignite a turnaround for the faded cancer star?

8 years ago

Focused on new deals, Biogen bags a PhIII drug for ischemic stroke with $120M upfront

8 years ago

Biogen shutters a biotech shop in the UK as it continues to prune R&D

8 years ago

Scott Gottlieb is sworn in as FDA commissioner

9 years ago

Regulators order AB Science to halt trial work on PhIII ALS drug, demanding proof it's cleaned up

9 years ago

Shares soar as ‘breakthrough’ news in biotech continues to run hot this week

9 years ago

It’s all quite satisfactory, merci: Sanofi chairman Serge Weinberg shrugs off growing calls for an M&A deal

9 years ago

Daiichi Sankyo sweeps out Pieris drug, 5 others in a Q1 pipeline cleanup

9 years ago

Merck increases grip on its lead in lung cancer, winning approval for Keytruda/chemo combo as first-line therapy

9 years ago

Pfizer expands gene therapy effort on hemophilia, bagging rights to a Sangamo drug in a $545M deal

9 years ago

New study points to a double-digit hike in branded drug prices, spotlighting a growing national debate

9 years ago

Scoop: Turing is considering a $100M cash offer for the drug that triggered a national scandal over drug pricing

9 years ago

It’s official: Senate confirms Scott Gottlieb as the country’s next FDA commissioner

9 years ago

PhRMA drums out 22 members who didn’t make the cut as major league R&D players

9 years ago

Sanofi takes its own drug pricing pledge, pointing to a decline in their aggregate net price

9 years ago

Takeda, Abingworth provide a $100M bankroll for an upstart T cell player, building in a buyout option

9 years ago

Was PTC Therapeutics playing games when it tried to defuse the deflazacort controversy with a $35,000 annual price?

9 years ago

First page Previous page 323 324 325326327 328 329 Next page Last page